Portal vein thrombosis screening: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Portal vein thrombosis}} | {{Portal vein thrombosis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{F.K}} | ||
==Overview== | ==Overview== | ||
Revision as of 20:35, 11 December 2017
Portal vein thrombosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Portal vein thrombosis screening On the Web |
American Roentgen Ray Society Images of Portal vein thrombosis screening |
Risk calculators and risk factors for Portal vein thrombosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There is insufficient evidence to recommend routine screening for portal vein thrombosis.